herenciageneticayenfermedad: Parkinson's Disease - Jan 11, 2019 Edition | Medical News

viernes, 11 de enero de 2019

Parkinson's Disease - Jan 11, 2019 Edition | Medical News | Medical Articles

	January 11, 2019
	Parkinson's Disease
	The latest Parkinson's disease news from News Medical

Using Multiplex Assays to Discover Biomarkers for Parkinson’s Disease

An interview with Dr. Nicole Polinski from The Michael J. Fox Foundation for Parkinson's Research (MJFF) and Dr. Elnaz Atabakhsh from Abcam, discussing the importance of developing biomarkers for Parkinson’s and the partnership between MJFF and Abcam.

			The Opal: Pushing the Boundaries of Parkinson’s Disease Research An interview with Kristen Sowalsky, DC, Ph.D., from APDM Wearable Technologies at SfN 2018, discussing the Opal wearable sensor and its impact on Parkinson’s disease research.

			Study reveals how Parkinson's disease protein 'buys time' for cell repair Australian researchers have discovered how a protein linked to Parkinson's disease may protect cells such as neurons in the brain. The study revealed how a protein called Parkin - which is lost in certain forms of Parkinson's disease - 'buys time' for cells to repair internal damage that may otherwise kill them.

	Defective astrocytes linked to alpha-synuclein accumulation in Parkinson's Researchers at the University of Barcelona have found that defects in brain glial cells called astrocytes are linked to the accumulation of alpha-synuclein; a toxic protein that is thought to contribute to Parkinson’s disease.

	Researchers identify promising new therapeutic target for Parkinson’s A study led by researchers at Brigham and Women’s Hospital and Harvard Medical School has shed light on the role fatty acids play in Parkinson’s disease and pointed towards an enzyme as a potential therapeutic target for the disease.

	Advanced stem cell approach could help fight Parkinson's disease Scientists have taken a key step toward improving an emerging class of treatments for Parkinson's disease. The advance could markedly improve a next generation of therapies for the condition, which affects around one in 350 people in the UK.

	Biologists discover how protein clumps damage cells in Parkinson's disease Biologists studying Parkinson's disease have long hoped to solve the mystery of the telltale "clumps." Scientists want to know how clumps of misfolded proteins damage brain cells and contribute to the disease.

	New study describes various gene therapy strategies for treating Parkinson's disease Parkinson's disease is a neurodegenerative disorder characterized by motor and nonmotor deficits majorly caused by the loss of dopaminergic cells in the Substantia Nigra pars compacta as well as the destruction of nigrostriatal pathway.

	Caffeine plus another compound in coffee may fight Parkinson’s disease Rutgers scientists have found a compound in coffee that may team up with caffeine to fight Parkinson's disease and Lewy body dementia - two progressive and currently incurable diseases associated with brain degeneration.

	Real-time neurofeedback controls Parkinson’s brainwaves A neurofeedback system enables Parkinson’s disease patients to voluntarily control brainwaves associated with symptoms of the disorder, according to new research published in eNeuro. It remains to be determined whether such a system can provide symptom relief.

	Pacemaker in the brain could help patients with epilepsy and Parkinsons Engineers and researchers at the University of California, Berkeley have developed a neurostimulator that can act as a pacemaker within the human brain.